ArticleAnnals of hematology2026

Gilteritinib response in acute myeloid leukemia harboring a rare FLT3 juxtamembrane domain mutation with subsequent clonal evolution.

Fumihiko Nakao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.